SERPASIL-APRESOLINE (HYDRALAZINE HYDROCHLORIDE; RESERPINE) — FDA Approval NDA009296 (NOVARTIS)
SERPASIL-APRESOLINE (HYDRALAZINE HYDROCHLORIDE; RESERPINE) — FDA Approval NDA009296 (NOVARTIS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SERPASIL-APRESOLINE; Active ingredients: HYDRALAZINE HYDROCHLORIDE; RESERPINE; Application number: NDA009296.
| Brand name | SERPASIL-APRESOLINE |
|---|---|
| Active ingredients | HYDRALAZINE HYDROCHLORIDE; RESERPINE |
| Application number | NDA009296 |
| Sponsor | NOVARTIS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19540401 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →